Kymera Therapeutics Inc - KYMR - stock price prediction, stock price target, analyst ratings from 23 analysts

Kymera Therapeutics Inc has a share price target of US$ 117, revenue growth forecast of 13.4%, and profit growth estimate of -31.7% for FY25, based on top 23 analyst calls.